Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yo-Han Kim

Showing results (111-120 of 113) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 113 results.
Yonsei Medical Journal|January 30, 2024
Reaching New Heights: A Comprehensive Study of Hand Transplantations in Korea after Institutionalization of Hand Transplantation LawYo Han Kim, Yun Rak Choi, Dong Jin Joo, et al.
International Journal of Clinical Pharmacology and Therapeutics|September 26, 2012
Assessment of the influence of severe renal impairment on the pharmacokinetics of mirodenafil in Korean male volunteersYook-Hwan Noh, Hyeong-Seok Lim, Sang-Heon Cho, et al.
Cancers|March 13, 2024
Combined Antitumor Effect of the Serine Protease Urokinase Inhibitor Upamostat and the Sphingosine Kinase 2 Inhibitor Opaganib on Cholangiocarcinoma Patient-Derived XenograftsFaizal Z Asumda, Nellie A Campbell, Mohamed A Hassan, et al.
Pageof 12

Showing results (111-120 of 113) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 113 results.
Yonsei Medical Journal|January 30, 2024
Reaching New Heights: A Comprehensive Study of Hand Transplantations in Korea after Institutionalization of Hand Transplantation LawYo Han Kim, Yun Rak Choi, Dong Jin Joo, et al.
International Journal of Clinical Pharmacology and Therapeutics|September 26, 2012
Assessment of the influence of severe renal impairment on the pharmacokinetics of mirodenafil in Korean male volunteersYook-Hwan Noh, Hyeong-Seok Lim, Sang-Heon Cho, et al.
Cancers|March 13, 2024
Combined Antitumor Effect of the Serine Protease Urokinase Inhibitor Upamostat and the Sphingosine Kinase 2 Inhibitor Opaganib on Cholangiocarcinoma Patient-Derived XenograftsFaizal Z Asumda, Nellie A Campbell, Mohamed A Hassan, et al.
Pageof 12